
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1016 | 987 | 1273 | 1572 | 2527 | 3812 |
Fund Return | 1.57% | -1.25% | 27.28% | 16.27% | 20.37% | 14.32% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AGF Global Select Series F CAD | 5.39B | 4.81 | 15.83 | 16.40 | ||
AGF American Growth Class Series T | 3.65B | 0.91 | 16.07 | 14.33 | ||
AGF Global Dividend Fund Series V | 2.49B | 5.53 | 12.41 | 7.58 | ||
AGF Global Dividend Fund CAD | 2.49B | 5.53 | 12.40 | 7.58 | ||
AGF Global Dividend Fund Series CAD | 2.49B | 5.74 | 13.72 | 8.83 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PH N US Multi Style All Cap Eq D | 9.21B | 2.06 | 16.68 | 12.65 | ||
PH N US Multi Style All Cap Eq F | 9.21B | 2.10 | 16.96 | 12.93 | ||
TD U.S. Blue Chip Equity Fund I CAD | 5.31B | 1.06 | 10.55 | 11.97 | ||
TD U.S. Blue Chip Equity Fund D CAD | 5.31B | 1.25 | 11.64 | - | ||
RBC Priv US Lg Cap Cr Eq Sr F CAD | 5.55B | 2.45 | 17.24 | 13.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amazon.com | US0231351067 | 7.47 | 196.59 | +1.05% | |
NVIDIA | US67066G1040 | 6.55 | 108.76 | +1.66% | |
Boston Scientific | US1011371077 | 4.75 | 95.52 | +1.48% | |
Alphabet A | US02079K3059 | 4.70 | 164.04 | -1.10% | |
Intuitive Surgical | US46120E6023 | 4.43 | 493.72 | +2.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review